Drawing for PULSE

USPTO serial 79437917

PULSE

Reviewed by CopyMark Law Group

Reg. 8497702Status 700Registered
Filing date
Status date
Registration date
Oct 13, 2026
Examiner
JAGDEO, KARA CECILIA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PULSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jessica S. Sachs

Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.100 Bloomfield Hills ParkwaySuite 200Bloomfield Hills, MI 48304

Goods and services

ClassDescriptionStatusFirst use
040Custom biomanufacturing of cell culture and cell therapy and gene edited cell therapy apparatus and equipment for others; custom biomanufacture of medicines; custom biomanufacture of biopharmaceuticals, namely, therapeutic cells, laboratory-modified cells, and gene edited cells to prevent or treat conditions or diseases that can be transferred into the body, for others; pharmaceutical manufacturing information, advice and consultancy in relation to all the aforesaidACTIVE—
042Platform-as-a-service (PaaS) featuring computer software platforms for research and development in the field of cell therapy, and cell therapy development; providing temporary use of a web-based online non-downloadable platform that offers tools, technologies, processes and data analysis capabilities for researchers and scientists to streamline the development and characterization of cell lines; providing temporary use of a technological online non-downloadable platform for the manufacturing of cell-based therapies, including technology, processes, and data analytics capabilities for process optimization and quality control; platform-as-a-service (PaaS) featuring computer software platforms for monitoring patient health; laboratory research in the field of biotechnology; scientific research, design and technological development services in biotechnology, the pharmaceutical and medical industry; scientific research, design and development of scientific cell culture, cell therapy or gene edited cell therapy equipment and apparatus; scientific research, design and development of cell culture, cell therapy or gene edited cell therapy manufacturing equipment, manufacturing systems and manufacturing processes for others; scientific research consultation services in the field of biotechnology, specifically in relation to cell culture, cell therapy, or gene edited cell therapy manufacturing; providing information with respect to scientific research in the field of stem cells, cell therapy and edited cell gene therapy; calibration services in the nature of initial set-up, configuration, and calibration, of scientific apparatus, machines and equipment used for cell culture, cell therapy and edited cell gene therapy; industrial biotechnology statistical analysis being biotechnology research to extract insights from cell line development experiments and data; scientific research and development in the field of cells, therapeutic cells, cell therapies, cellular therapies and gene edited cell therapies; culturing of cells for scientific research purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 13, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 13, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 25, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 25, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 20, 2026GPNXNOTIFICATION PROCESSED BY IB—
Aug 19, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 5, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 5, 2026OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 25, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 17, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 17, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 17, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 28, 2026RFNTREFUSAL PROCESSED BY IB—
May 13, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 13, 2026RFRRREFUSAL PROCESSED BY MPU—
Mar 28, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 27, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2026DOCKASSIGNED TO EXAMINER—
Dec 2, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 2, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 27, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance